Early Trial Suggests that Targeting CLL1-Postive Cells is Effective in Treating Pediatric AML
Oncology Nursing News,
Findings presented at the 2021Annual Society of Clinical Oncology Annual Meeting revealed that targeting CLL 1-Positive Cells…
Findings presented at the 2021Annual Society of Clinical Oncology Annual Meeting revealed that targeting CLL 1-Positive Cells…
Feasibility of chimeric antigen receptor (CAR) T-cell therapy targeting C-type lectin-like molecule-1 (CLL-1) for pediatric…
In an interim analysis from the phase 1/2 trial (ChiCTR1900027684), 10 of 11 patients completely responded to anti-CLL1–based…